bpc-157 interstitial cystitis pilot study 2024 Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System Urobiome Analysis in Interstitial Cystitis/Bladder
Description
By day 4, the plasma dUrd levels remained elevated relative to baseline, although this did not reach statistical significance (103 nmol l 1 , 154%, NS)
Commonly Reported Injection site reactions some redness, swelling, or itching that clears up within 30 minutes
Aging 12 , 94479460 (2020)
Symptoms can include swelling, hives, or difficulty breathing
